Related Experiment Video
Updated: Dec 18, 2025
06:52
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
6.9K
Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic
Vívian D'Afonseca1, Ariel D Arencibia2, Alex Echeverría-Vega1
1Centro de Investigación de Estudios Avanzados del Maule (CIEAM), Vicerrectoría de Investigación y Postgrado, Universidad Católica del Maule, Talca, Chile.
Cancer Informatics
|June 18, 2020
Summary
Researchers identified key genetic alterations in gallbladder cancer (GBC), a rare but deadly biliary tract tumor. These findings may lead to new diagnostic tools and prognostic profiles for GBC, improving patient outcomes.
Area of Science:
- Oncology
- Genetics
- Genomics
Background:
- Gallbladder cancer (GBC) is a rare biliary tract cancer with high incidence in specific regions.
- Current diagnostic methods and molecular markers for GBC are lacking.
- Accurate prognostic markers are needed to evaluate patient survival and treatment options.
Purpose of the Study:
- To identify and characterize somatic mutations and copy number alterations in GBC.
- To propose a genetic alteration atlas for GBC.
- To explore potential diagnostic and prognostic markers for GBC.
Main Methods:
- Data-mining of 133 GBC samples from public repositories.
- Analysis of somatic mutations in key genes.
- Identification of genes with copy number alterations.
Main Results:
- Identified 14 frequently altered genes in GBC, including *TP53*, *KRAS*, and *ERBB2*, with missense mutations being common.
- Found several probable oncogenic and hotspot mutations, potentially linked to poor prognosis.
- Identified 11 additional genes with copy number alterations, such as *MYC* and *CCND1*.
Conclusions:
- The identified genetic alterations provide a foundation for developing novel diagnostic systems for GBC.
- Proposed genetic alterations can aid in creating prognostic profiles for GBC.
- These findings contribute to understanding GBC development and prevalence.
